BioNTech announces positive results of an international reproducibility study with MammaTyper®

International multicenter study in ten pathology laboratories…

BioNTech to present interim Phase I/II date for mRNA vaccine at AACR

Mainz, Germany, March 7, 2017 - BioNTech AG, a fully-integrated…

BioNTech to Present at 35th Annual J.P. Morgan Healthcare Conference 2017

Mainz, Germany, 22nd December 2016: BioNTech AG, a fully integrated…

BioNTech to enter into worldwide strategic collaboration with Genentech to develop individualized mRNA cancer therapies

Mainz, Germany, September 21, 2016 - BioNTech AG, a fully integrated…

Chinese FDA Grants MammaTyper® Innovative Product Status for Expedited Approval

Mainz, Germany and Deqing, China, August 19, 2016 — BioNTech…

Study confirms advantages of the in vitro diagnostic test kit MammaTyper® over immunohistochemistry (IHC)

Mainz, Germany, June 16, 2016: BioNTech Diagnostics GmbH, a subsidiary…